We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTS icon
1826
CarParts.com
PRTS
$42.4M
$1.58M ﹤0.01%
25,164
+20,891
+489% +$1.09M
PEGR
1827
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$1.57M ﹤0.01%
156,316
BF.B icon
1828
Brown-Forman Class B
BF.B
$13.3B
$1.57M ﹤0.01%
23,962
+13,926
+139% +$945K
SDAWW
1829
CALL
SunCar Technology Group Warrant
SDAWW
$12.3M
$1.57M ﹤0.01%
150,000
PINE
1830
Alpine Income Property Trust
PINE
$337M
$1.56M ﹤0.01%
+81,777
New +$1.48M
AMWD
1831
DELISTED
American Woodmark
AMWD
$1.56M ﹤0.01%
31,932
+5,137
+19% +$255K
DXC icon
1832
DXC Technology
DXC
$1.76B
$1.56M ﹤0.01%
58,853
-187,196
-76% -$5.21M
PRQR icon
1833
ProQR Therapeutics
PRQR
$248M
$1.56M ﹤0.01%
420,615
+347,185
+473% +$455K
RCFA.WS
1834
CALL
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$1.55M ﹤0.01%
151,183
GGAA
1835
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
$1.55M ﹤0.01%
149,998
MEDP icon
1836
Medpace
MEDP
$15.9B
$1.55M ﹤0.01%
+7,300
New +$1.46M
TVGNW icon
1837
CALL
Tevogen Bio Warrant
TVGNW
$9.64M
$1.55M ﹤0.01%
149,999
FDMT icon
1838
4D Molecular Therapeutics
FDMT
$515M
$1.55M ﹤0.01%
+69,747
New +$1.08M
ACDI.WS
1839
CALL
DELISTED
Ascendant Digital Acquisition Corp. III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11. 50 per share
ACDI.WS
$1.55M ﹤0.01%
149,999
CXAC.WS
1840
CALL
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
$1.55M ﹤0.01%
149,998
USCTW
1841
CALL
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
$1.55M ﹤0.01%
149,999
XMTR icon
1842
Xometry
XMTR
$4.58B
$1.55M ﹤0.01%
47,948
+29,535
+160% +$1.38M
GEEXW
1843
CALL
DELISTED
Games & Esports Experience Acquisition Corp. Warrants
GEEXW
$1.54M ﹤0.01%
149,999
RNWWW
1844
CALL
ReNew Energy Global PLC Warrant
RNWWW
$63K
$1.54M ﹤0.01%
280,000
GCMGW
1845
CALL
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
$1.54M ﹤0.01%
202,020
+2,020
+1% +$1.22K
ROCC
1846
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.54M ﹤0.01%
37,994
-11,412
-23% -$452K
HRZN icon
1847
Horizon Technology Finance
HRZN
$295M
$1.54M ﹤0.01%
132,420
-1,214
-0.9% -$14.5K
PRCH icon
1848
Porch Group
PRCH
$1.38B
$1.53M ﹤0.01%
816,262
-586,845
-42% -$1.04M
SBC
1849
SBC Medical Group
SBC
$329M
$1.53M ﹤0.01%
149,704
SBCWW
1850
CALL
SBC Medical Group Warrants
SBCWW
$1.53M ﹤0.01%
149,704

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.